Prokocimer Philippe 4
4 · Trius Therapeutics Inc · Filed May 28, 2013
Insider Transaction Report
Form 4
Prokocimer Philippe
Chief Medical Officer
Transactions
- Sale
Common Stock
2013-05-24$7.93/sh−12,000$95,119→ 86,022 total(indirect: By Trust)
Holdings
- 10,429
Common Stock
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2012
- [F2]The weighted average sales price for the transaction reported was $7.926667, and the range of prices were between $7.92 and $7.96. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided